The FDA has reported adverse-event concerns involving compounded semaglutide and tirzepatide, including dosing errors, gastrointestinal symptoms, and events that required medical attention
Dark Spot Reduction: Helps reduce the appearance of dark spots, melasma, and pigmentation
Some of our key ingredients Glutathione The protein molecule hailed as the master antioxidant has been linked with healthier aging, improved detoxification, decreased weight, and a lower rate of almost all health issues
It is not a medicine
FDA approves first treatment for hypoactive sexual desire disorder in premenopausal women
On June 12, 2023, Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that new findings for efinopegdutide (MK-6024), an investigational GLP-1/glucagon receptor co-agonist, have been accepted for oral presentation at the European Association for the Study of the Liver (EASL) Annual Congress from June 21-24
